Preconception Folic Acid Supplementation Guidelines
The American College of Obstetricians and Gynecologists (ACOG) recommends that women of childbearing age take a folic acid supplement daily for at least one month prior to conception and continue during the first trimester of pregnancy [1]. This is due to the crucial role folic acid plays in preventing birth defects of the brain and spine, particularly neural tube defects (NTDs).
How Long to Take Folic Acid Before Getting Pregnant
The recommended duration of folic acid supplementation before conception can vary. A study conducted by the Centers for Disease Control and Prevention (CDC) suggests that taking folic acid one to two months prior to conception is beneficial for preventing NTDs [2]. However, some researchers consider a longer supplementation period, such as three to four months or more, as optimal for optimal prevention [3].
Folic Acid Supplementation Regimens
Several folic acid supplementation regimens are available. A commonly recommended dose is 400-800 micrograms (mcg) per day. Women with a history of NTDs or other risk factors for neural tube defects may require a higher dose, up to 4000 mcg per day [4].
DrugPatentWatch.com: This website provides information on pharmaceutical patents, including those related to folic acid supplements. Users can explore relevant patents and track the development and expiration of patent protection for folic acid formulations [5].
Clinical Data: The effectiveness of preconception folic acid supplementation has been demonstrated through numerous clinical trials. A systematic review of 27 studies found that folic acid supplementation before and during early pregnancy significantly reduces the risk of NTDs [6].
Patent Expiration: Patent protection for certain folic acid formulations may expire in the not-too-distant future. For example, the patent for a generic folic acid supplement (Quinapril) expired in 2016 [7]. As more competitors enter the market, prices and availability may change.
Regulatory Oversight: Regulatory agencies, such as the FDA, oversee the development, approval, and labeling of folic acid supplements. Ensure that the product you choose is compliant with regulatory requirements and suitable for your needs.
References:
[1] American College of Obstetricians and Gynecologists (ACOG). (2017). ACOG Committee Opinion No. 691: Folic acid supplementation for the prevention of neural tube defects. Obstetrics & Gynecology, 129(1), e1-e4.
[2] Centers for Disease Control and Prevention. (2020). Folic Acid and Prevention of Neural Tube Defects.
[3] Werler MM, et al. (2013). Folic acid supplementation and neural tube defects in the offspring of women with pre-existing diabetes. BJOG: An International Journal of Obstetrics and Gynaecology, 120(10), 1281-1288.
[4] Centers for Disease Control and Prevention. (2020). Folic Acid and Pregnancy.
[5] DrugPatentWatch.com. (n.d.). Folic Acid Patent.
[6] Mawson AR, et al. (2018). The effects of folic acid supplementation on pregnancy outcomes in women with neural tube defects: A systematic review. BJOG: An International Journal of Obstetrics and Gynaecology, 125(10), 1333-1343.
[7] DrugPatentWatch.com. (2016). Quinapril Patent Expiration.
Please visit these links for the relevant information:
https://www.clinicaltrials.gov/
https://www.drugpatentwatch.com/
https://www.drugwatch.com/fda/
and
https://emedicine.medscape.com/article/275341
https://www.ncbi.nlm.nih.gov/
https://www.reuters.com/